Washington University Team Explores Link Between Birth Defects & Pediatric Cancer
Some children who are born with birth defects may be more likely to develop certain types of pediatric cancer, according to a groundbreaking new study... Read More
Thank You
Thank you for submitting a free case evaluation form. Our Zofran lawyers will review this as soon as possible and contact you for more information.
If you have any questions, please call us on (877) 620-8411.
New Study: Obesity Increases Risk Of Major Birth Defects
Researchers have long known that obese women appear to deliver more children with congenital malformations than pregnant women who maintain lower body weights. A new... Read More
Birth Defect Research Still Lags Behind, Utah Experts Find
Most congenital anomalies (birth defects) go unexplained, according to a new study from genetic researchers at the University of Utah School of Medicine. In their... Read More
GSK Fights To Strike Fraud-Related Zofran Lawsuit Claims
In their Zofran lawsuits, hundreds of families accuse GlaxoSmithKline of guiding a sweeping – and illegal – marketing campaign to convince obstetricians into prescribing the... Read More
Three-Year-Old Girl Undergoes First Cleft Palate Repair On St. Thomas
After years searching for adequate treatment, a young girl from St. Thomas has become the first patient to undergo cleft palate repair in the US... Read More
Zofran Leads Competition In Morning Sickness Drug Market
Despite widespread concerns over the nausea drug’s safety, pregnant women continue to be prescribed staggering amounts of Zofran, according to a new report from researchers... Read More
GlaxoSmithKline Tells Federal Judge To Strike Zofran Lawsuit Fraud Claims
In recent court filings, attorneys for multinational pharmaceutical conglomerate GlaxoSmithKline have asked a Massachusetts federal judge to dismiss the fraud-based claims leveled by hundreds of families,... Read More
Toronto Physicians Voice Concern Over Evidence Behind Morning Sickness Drug
Two Toronto researchers have expressed their doubts about the efficacy of Diclegis, the only drug approved to treat morning sickness in both Canada and the United States.... Read More